Polydimethylsiloxane/polyether-mixed macrodiol-based polyurethane elastomers: biostability.
暂无分享,去创建一个
K Schindhelm | G. Meijs | D. Martin | K. Schindhelm | P. Gunatillake | D J Martin | L A Warren | P A Gunatillake | S J McCarthy | G F Meijs | S. Mccarthy | L. Warren | Klaus Schindhelm | Darren J. Martin | Laura A. Poole Warren
[1] S. Cooper,et al. Synthesis, characterization and ex vivo evaluation of poly-dimethylsiloxane polyurea-urethanes , 1994 .
[2] James M. Anderson,et al. Polyurethane Elastomer Biostability , 1995, Journal of biomaterials applications.
[3] J. Santerre,et al. Application of macromolecular additives to reduce the hydrolytic degradation of polyurethanes by lysosomal enzymes. , 1997, Biomaterials.
[4] J. Santerre,et al. The effect of phospholipids on the biodegradation of polyurethanes by lysosomal enzymes. , 1997, Journal of biomaterials science. Polymer edition.
[5] A. Hiltner,et al. Cellular interactions with biomaterials: in vivo cracking of pre-stressed Pellethane 2363-80A. , 1990, Journal of biomedical materials research.
[6] C. Capone,et al. Biostability of a Non-Ether Polyurethane , 1992, Journal of biomaterials applications.
[7] H. Planck,et al. Polyurethanes in Biomedical Engineering , 1984 .
[8] Arnold Lustiger. Understanding Environmental Stress Cracking in Polyethylene , 1998 .
[9] S. Cooper,et al. Blood-contacting properties of polydimethylsiloxane polyurea-urethanes. , 1994, Biomaterials.
[10] M Szycher,et al. In vivo Testing of a Biostable Polyurethane , 1991, Journal of biomaterials applications.
[11] P. Urbański,et al. Glass wool-H2O2/CoCl2 test system for in vitro evaluation of biodegradative stress cracking in polyurethane elastomers. , 1995, Journal of biomedical materials research.
[12] J M Anderson,et al. In vivo biocompatibility and biostability of modified polyurethanes. , 1997, Journal of biomedical materials research.
[13] W S Pierce,et al. Segmented Polyurethane: A New Elastomer for Biomedical Applications , 1967, Science.
[14] Darren J. Martin,et al. The effect of average soft segment length on morphology and properties of a series of polyurethane elastomers. I. Characterization of the series , 1996 .
[15] Darren J. Martin,et al. The influence of composition ratio on the morphology of biomedical polyurethanes , 1999 .
[16] R. Guidoin,et al. Chemical stability of polyether urethanes versus polycarbonate urethanes. , 1997, Journal of biomedical materials research.
[17] Darren J. Martin,et al. The effect of average soft segment length on morphology and properties of a series of polyurethane elastomers. II. SAXS‐DSC annealing study , 1997 .
[18] J. Santerre,et al. Neutrophil-mediated degradation of segmented polyurethanes. , 1995, Biomaterials.
[19] D. Williams,et al. Mechanisms of biodegradation of implantable polymers. , 1992, Clinical materials.
[20] J. Santerre,et al. Differential synthesis of cholesterol esterase by monocyte-derived macrophages cultured on poly(ether or ester)-based poly(urethane)s. , 1998, Journal of biomedical materials research.
[21] A. M. Reed,et al. A Solution Grade Biostable Polyurethane Elastomer: ChronoFlex® AR , 1994, Journal of biomaterials applications.
[22] Darren J. Martin,et al. Effect of soft-segment CH2/O ratio on morphology and properties of a series of polyurethane elastomers , 1996 .
[23] S. Sakurai,et al. Structure characterization of polyurethanes containing poly(dimethylsiloxane) , 1991 .
[24] J. Santerre,et al. Enzyme-biomaterial interactions: effect of biosystems on degradation of polyurethanes. , 1993, Journal of biomedical materials research.
[25] H. Griesser. Degradation of polyurethanes in biomedical applications—A review , 1991 .
[26] J. Shin,et al. Synthesis and characterization of poly(siloxane‐urethane)s , 1992 .